Related Experiment Video
Updated: Oct 29, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients
İbrahim Halil Özdemir1, Bülent Özlek2, Mehmet Burak Özen1
1Department of Cardiology, Manisa City Hospital, Manisa, TURKEY.
Insights
The C-reactive protein/albumin ratio (CAR) is a strong predictor of mortality in hypertensive COVID-19 patients. Higher CAR levels indicate a worse prognosis and increased risk of death.
Area of Science:
- Clinical Medicine
- Infectious Diseases
- Cardiology
Background:
- Hypertension is a common comorbidity in COVID-19 patients.
- Predictive markers for COVID-19 prognosis are crucial for patient management.
Purpose of the Study:
- To investigate the prognostic value of the C-reactive protein/albumin ratio (CAR) in hypertensive COVID-19 patients.
- To determine if CAR can predict mortality in this patient group.
Main Methods:
- Single-center retrospective study of 281 hypertensive, ICU-admitted COVID-19 patients.
- Comparison of CAR levels between survivor and non-survivor groups.
- Logistic regression analysis to evaluate CAR's effect on mortality.
Main Results:
- CAR was significantly higher in non-survivors (p<0.001).
- CAR demonstrated an area under the ROC curve of 0.807 for mortality prediction.
- A CAR cut-off value of 56.62 predicted a 4.9-fold increase in mortality risk.
Conclusions:
- CAR is a powerful and independent prognostic marker for hypertensive COVID-19 patients.
- CAR can effectively predict mortality and disease progression.
Objectives:
The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients.
Methods:
It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were compared. The cut-off value was determined as a mortality predictor. The effect of CAR on mortality was evaluated using Logistic Regression analysis.
Results:
281 patients were included in the study. Groups consisted of 135 (non-survivor) and 146 (survivor) patients. CAR was significantly higher in the non-survivor group (p<0.001). The area under the ROC curve for CAR for mortality was 0.807, with sensitivity of 0.71 and specificity of 0.71. The cut-off value for CAR was calculated as 56.62. In logistic regression analysis, CAR increases mortality 4.9 times compared to the cut-off value.
Conclusion:
CAR is a powerful and independent prognostic marker for predicting mortality and disease progression in hypertensive COVID-19 patients.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pneumonia III: Complications and Assessment
Acute Kidney Injury IV: Diagnostic Studies and Prevention

